Skip to content

Welcome to Discover Pharma! Today is : November 8, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Drug Discovery & Development

  • Biotech & Pharma Business,Drug Discovery & Development,Pharmaceuticals and therapeutics

    Bionyra launches with $165M Series A to advance immunology biologics pipeline

    bionyra-pharma-series-a-immunology Bionyra Pharma has launched with a $165 million Series [...]

    June 22, 2026
  • Advanced Therapies,Drug Discovery & Development

    Spot Biosystems reports early clinical evidence for non-viral dystrophin delivery in Duchenne muscular dystrophy

    Spot Biosystems has emerged from stealth with $40 million in [...]

    June 18, 2026
  • Biotech & Pharma Business,Drug Discovery & Development,Manufacturing & Supply Chain

    Microbial manufacturing enters a new era of scale and complexity

    As demand grows for increasingly complex biologics, microbial manufacturing is [...]

    June 18, 2026
  • Advanced Therapies,Drug Discovery & Development,Therapeutic Areas

    Resolution Therapeutics expands regenerative macrophage pipeline with in vivo mRNA programme

    Resolution Therapeutics has expanded its regenerative macrophage therapy pipeline with [...]

    June 18, 2026
  • Biotech & Pharma Business,Clinical & Regulatory,Drug Discovery & Development,Pharmaceuticals and therapeutics,Therapeutic Areas

    Cystic Fibrosis Foundation backs SpliSense with up to $13m to advance SPL84 Phase 2b study

    spliesense-cystic-fibrosis-foundation-spl84-phase2b SpliSense has secured up to $13 million in funding [...]

    June 16, 2026
  • Biotech & Pharma Business,Drug Discovery & Development,Pharmaceuticals and therapeutics,Therapeutic Areas

    Mabion revives MabionCD20 through rare disease collaboration with Oddifact

    Mabion has signed a letter of intent with French technology [...]

    June 16, 2026
  • Drug Discovery & Development,Pharmaceuticals and therapeutics,Therapeutic Areas

    Innovative Molecules adds Epstein-Barr virus antiviral programme to pipeline

    Innovative Molecules has expanded its virology pipeline with a new [...]

    June 16, 2026
  • Clinical & Regulatory,Drug Discovery & Development,Pharmaceuticals and therapeutics,Therapeutic Areas

    Confo Therapeutics reports preclinical data for post-bariatric hypoglycaemia candidate at ENDO 2026

    Confo Therapeutics has presented preclinical data supporting the development of [...]

    June 16, 2026
  • Drug Discovery & Development,Pharmaceuticals and therapeutics,Therapeutic Areas

    Lonza licenses dual-payload ADC technology to Antharis for GI cancers

    Lonza has entered an exclusive licensing agreement with Antharis Therapeutics [...]

    June 16, 2026
  • Biotech & Pharma Business,Drug Discovery & Development

    ZoBio launches DNA-encoded library hit discovery service for difficult drug targets

    ZoBio has launched a DNA-encoded library (DEL) hit discovery service [...]

    June 16, 2026
Previous131415Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Big Picture Bio launches with £2.2M to design cancer drug combinations
    Categories: Biotech & Pharma Business, Drug Discovery & Development, Pharmaceuticals and therapeutics, Research & Development, Therapeutic Areas
  • SKY-0515 shows 1.59-point cUHDRS difference in Huntington’s disease study
    Categories: Central Nervous System, Clinical & Regulatory, Pharmaceuticals and therapeutics, Research & Development
  • Oncodesign Services and Nexus BioQuest form preclinical research partnership
    Categories: Advanced Therapies, Biotech & Pharma Business, Research & Development
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details.
OK
Go to Top